Art Pappas

Art Pappas is CEO & Managing General Partner at Pappas Capital, where he invests in life sciences. He backs companies across Seed through late-stage rounds (including Seed, Series A–D and F, Venture and Private Equity rounds, and Post-IPO Equity) in the United States and Canada, including activity in Boston/Cambridge, MA and North Carolina. He has invested in companies like CoLucid Pharmaceuticals, Chimerix, AtheroGenics, Embrex, and Quintiles Transnational. Previously, he was Chief Executive for International Operations (Asia Pacific, Canada, Latin America) at Glaxo Holdings plc; Vice President, International Commercial Operations at Abbott Laboratories International Ltd.; and held general management, marketing, and sales roles in international and domestic operations at Merrell Dow Pharmaceuticals – The Dow Chemical Co. Art holds a BS in Biology from Ohio State University and an MBA in Finance from Xavier University, and he lives in Durham, North Carolina.